Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 28 Jul 2017 |
2 | Reply to Exam Report (MIS-R) | 23 Sep 2017 |
3 | Journal Copy | 26 Jun 2019 |
4 | TM-O(NOTICE OF OPPOSITION) | 27 Aug 2019 |
5 | Annexure -1 under rule 46 | 13 Mar 2020 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 13 Mar 2020 |
6 | Annexure -1 under rule 46 | 13 Mar 2020 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 13 Mar 2020 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 16 Mar 2020 |
1 | Hearing Notice (Show Cause) | 7896531 | 3952564 | 05 Mar 2019 |
2 | Tribunal Accepted Notice for : 3601516 | 8148569 | 4001431 | 22 Apr 2019 |
3 | Opposition Notice | 8934331 | 4396967 | 17 Sep 2019 |
4 | Opposition Counter Statement | 9287883 | 4557418 | 22 Nov 2019 |
The application for Emvarin was made on 28 July 2017.
The trademark applicant for Emvarin is EMCURE PHARMACEUTICALS.
Emvarin is applied in class(es) 5.
Application for Emvarin is on Opposed stage.
Application Id allotted to Emvarin is 3601516.
Trademark agent or attorney for the application is Aditya & Associates.
Emvarin filed with the Intellectual property office as a WORD.